drugset / Trial / NCT06581380
JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study was designed to compare the efficacy and safety of JK-1201I with Topotecan in patients with relapsed extensive stage small cell lung cancer (ES SCLC).
Timeline
- Start
- 2024-09-16
- Primary completion
- 2027-11-16
- Completion
- 2028-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JK-1201I | Unknown | 180 mg/m2 | Intravenous |
| Comparator | Topotecan | Small molecule | — | — |